# Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)

> **NCT01956279** · PHASE2 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 170 (actual)

## Conditions studied

- Fatigue
- Musculoskeletal Pain
- Cognitive Decline

## Interventions

- **DRUG:** Pregnenolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01956279
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-01
- **Primary completion:** 2018-10-10
- **Final completion:** 2018-10-10
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2020-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01956279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01956279, "Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT01956279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*